These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 3898756)

  • 21. Tumor cell lipid composition and sensitivity to humoral immune killing. II. Influence of plasma membrane and intracellular lipid and fatty acid content.
    Schlager SI; Ohanian SH
    J Immunol; 1980 Aug; 125(2):508-17. PubMed ID: 7391566
    [No Abstract]   [Full Text] [Related]  

  • 22. Mechanism of tumor cell resistance to lysis by syngeneic lymphocytes.
    Fidler IJ; Bucana C
    Cancer Res; 1977 Nov; 37(11):3945-56. PubMed ID: 908034
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Inhibition of cytolysin activity in large granular lymphocyte granules by lipids: evidence for a membrane insertion mechanism of lysis.
    Yue CC; Reynolds CW; Henkart PA
    Mol Immunol; 1987 Jun; 24(6):647-53. PubMed ID: 3657801
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Linkage of a membrane skeleton to integral membrane glycoproteins in human platelets. Identification of one of the glycoproteins as glycoprotein Ib.
    Fox JE
    J Clin Invest; 1985 Oct; 76(4):1673-83. PubMed ID: 2932470
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Inhibition of mouse tumor cells in vitro by contact with lymph node and tumor cells containing foreign H-2 antigens.
    Hellström KE; Hellström I
    Fed Proc; 1968; 27(1):39-41. PubMed ID: 4952629
    [No Abstract]   [Full Text] [Related]  

  • 26. In vitro retrieval of the cytotoxic potential of spleen cells of tumor-bearing mice.
    Schechter B; Feldman M
    Isr J Med Sci; 1978 Jan; 14(1):131-45. PubMed ID: 632079
    [No Abstract]   [Full Text] [Related]  

  • 27. Foreign H-2-like alloantigens of syngeneic tumor cells can act as new "restriction" molecules for the associative recognition of non-H-2 or tumor-associated antigens by lymphoid effectors in the cytostasis assay.
    Festenstein H; de Giorgi L; Matossian-Rogers A
    Transplant Proc; 1981 Dec; 13(4):1877-9. PubMed ID: 7330973
    [No Abstract]   [Full Text] [Related]  

  • 28. Omega-3 fatty acid modification of membrane structure and function. II. Alteration by docosahexaenoic acid of tumor cell sensitivity to immune cytolysis.
    Pascale AW; Ehringer WD; Stillwell W; Sturdevant LK; Jenski LJ
    Nutr Cancer; 1993; 19(2):147-57. PubMed ID: 8502585
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Cytostatic effect of immune system cells on tumor cells].
    Bogdashin IV
    Biull Eksp Biol Med; 1986 Jun; 101(6):744-6. PubMed ID: 3730565
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Lymphocyte mediated reactivity against malignant melanoma detected by a microcytotoxicity assay employing technetium-99m labeled target cells.
    Gillespie GY; Barth RF
    Cancer; 1978 Jun; 41(6):2174-82. PubMed ID: 350374
    [No Abstract]   [Full Text] [Related]  

  • 31. Tumorigenicity and lysis by natural killers.
    Collins JL; Patek PQ; Cohn M
    J Exp Med; 1981 Jan; 153(1):89-106. PubMed ID: 6161207
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antigenic changes of DBA/2J mastocytoma cells when grown in the BALB/c mouse.
    Wolf JE; Faanes RB; Choi YS
    J Natl Cancer Inst; 1977 May; 58(5):1407-12. PubMed ID: 67213
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The surface antigenicity of serially transplantable malignant human lymphoid cells derived from subjects with infectious mononucleosis, Hodgkin's disease, chronic lymphatic leukemia, or acute lymphoblastic leukemia.
    Galli SJ; Adams RA
    Cancer Res; 1974 Feb; 34(2):298-303. PubMed ID: 4589952
    [No Abstract]   [Full Text] [Related]  

  • 34. Immune plasma-dependent cytotoxicity of immune and non-immune peripheral lymphoid cells for target cells coated with bacterial outer unit membrane.
    Torten M; Johnson RC; Kaattari S; Leung C; Benjamini E
    Immunology; 1975 Dec; 29(6):1093-102. PubMed ID: 1193683
    [TBL] [Abstract][Full Text] [Related]  

  • 35. In vitro induction of tumor-specific immunity. II. Activation of cytotoxic lymphocytes to murine oncofetal antigens.
    Chism SE; Burton RC; Warner NL
    J Natl Cancer Inst; 1976 Aug; 57(2):377-87. PubMed ID: 63560
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Immunologically mediated membrane damage: the mechanism of complement action and the similarity of lymphocyte-mediated cytotoxicity.
    Mayer MM; Hammer CH; Michaels DW; Shin ML
    Transplant Proc; 1978 Dec; 10(4):707-14. PubMed ID: 366830
    [No Abstract]   [Full Text] [Related]  

  • 37. [Human lymphocyte membrane markers in lymphoproliferative diseases (proceedings)].
    Giunchi G; Franchi F
    Minerva Med; 1977 Oct; 68(50):3441-6. PubMed ID: 270617
    [No Abstract]   [Full Text] [Related]  

  • 38. In vitro induction of lymphoblasts and cytotoxic lymphocytes with prostate tumor cells.
    Frost P; Rose NR
    Natl Cancer Inst Monogr; 1978 Dec; (49):169-72. PubMed ID: 571044
    [No Abstract]   [Full Text] [Related]  

  • 39. Co-operation between macrophages and a factor from lymphocytes in tumor lysis in vitro.
    Yamazaki M; Shinoda H; Mizuno D
    Gan; 1975 Oct; 66(5):489-97. PubMed ID: 1082827
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Surface markers of small lymphocytes appearing in murine TA-3(St) solid tumors, host spleen, and blood.
    Lala PK; Kaizer L
    J Natl Cancer Inst; 1977 Jul; 59(1):237-44. PubMed ID: 301572
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.